gabapentin has been researched along with carbamates in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Field, MJ; Gonzalez, MI; Singh, L; Tallarida, RJ | 1 |
| Rekling, JC | 1 |
| Dost, R; Rostock, A; Rundfeldt, C | 1 |
| Barrett, RW; Branch, R; Chernov-Rogan, T; Cundy, KC; Dias, T; Estrada, T; Gallop, MA; Hold, K; Koller, K; Liu, X; Mann, A; Panuwat, M; Raillard, SP; Upadhyay, S; Wu, QQ; Xiang, JN; Yan, H; Zerangue, N; Zhou, CX | 1 |
| Annamalai, T; Barrett, RW; Bu, L; Cundy, KC; De Vera, J; Estrela, J; Gallop, MA; Luo, W; Shirsat, P; Torneros, A; Yao, F; Zou, J | 1 |
| Green, AC; Harrison, PK; Sheridan, RD; Tattersall, JE | 1 |
| Miura, Y | 1 |
| Canafax, DM; Cundy, KC; Luo, W; Moors, TL; Sastry, S; Zou, J | 1 |
| Barrett, RW; Becker, PM; Canafax, DM; Ellenbogen, AL; Kushida, CA | 1 |
| Cundy, KC; Huff, FJ; Lal, R; Luo, W; Sukbuntherng, J; Zou, J | 1 |
| Backonja, MM; Canafax, DM; Cundy, KC | 1 |
| de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M | 1 |
| Cundy, KC; Lal, R; Lassauzet, ML; Luo, W; Sukbuntherng, J; Tovera, J | 1 |
| Chen, C | 1 |
| Chronicle, EP; Linde, M; McCrory, DC; Mulleners, WM | 1 |
| Argoff, CE; Harden, RN; Kaye, AD; Kintanar, T | 1 |
| Earley, CJ | 1 |
| Arumugham, T; Chen, C; Davy, M; Stier, B; Upward, J | 1 |
| Jergova, S; Nasirinezhad, F; Pearson, JP; Sagen, J | 1 |
| Bastin, ML; Cook, AM; Oyler, DR; Smetana, KS | 1 |
| Wang, J; Zhu, Y | 1 |
| Faulkner, MA | 1 |
| Ambrosino, P; Binda, A; Canafoglia, L; Castellotti, B; DiFrancesco, JC; Freri, E; Gellera, C; Granata, T; Labalme, A; Lesca, G; Messina, G; Mosca, I; Murano, C; Ragona, F; Rivolta, I; Solazzi, R; Soldovieri, MV; Taglialatela, M; Vannicola, C | 1 |
| Ellenbogen, A; Gidal, B; Lal, R | 1 |
9 review(s) available for gabapentin and carbamates
| Article | Year |
|---|---|
[A new aspect in the research on antiepileptic drugs].
Topics: Acetamides; Amines; Animals; Anticonvulsants; Benzodiazepines; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Humans; Lacosamide; Levetiracetam; Phenylenediamines; Piracetam; Pregabalin; Pregnanolone; Pyrrolidinones; Triazoles | 2007 |
ADMET considerations for restless leg syndrome drug treatments.
Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil.
Topics: Administration, Oral; Amines; Biological Availability; Carbamates; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Administration Schedule; Gabapentin; gamma-Aminobutyric Acid; Humans; Models, Biological; Prodrugs | 2013 |
Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.
Topics: Adult; Amines; Anticonvulsants; Carbamates; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Migraine Disorders; Pregabalin; Randomized Controlled Trials as Topic | 2013 |
Evidence-based guidance for the management of postherpetic neuralgia in primary care.
Topics: Amines; Analgesics; Capsaicin; Carbamates; Cyclohexanecarboxylic Acids; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia, Postherpetic; Practice Guidelines as Topic; Pregabalin; Primary Health Care | 2013 |
Latest guidelines and advances for treatment of restless legs syndrome.
Topics: Amines; Analgesics, Opioid; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Iron Compounds; Pregabalin; Restless Legs Syndrome | 2014 |
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.
Topics: Acetamides; Acute Kidney Injury; Amines; Anticonvulsants; Carbamates; Critical Illness; Cyclohexanecarboxylic Acids; Dibenzazepines; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Renal Dialysis; Renal Replacement Therapy; Seizures; Topiramate; Triazines; Valproic Acid; Zonisamide | 2016 |
Different doses of gabapentin formulations for postherpetic neuralgia: A systematical review and meta-analysis of randomized controlled trials.
Topics: Amines; Analgesics; Carbamates; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia, Postherpetic; Randomized Controlled Trials as Topic | 2017 |
Use of α2δ Ligands for Restless Legs Syndrome/Willis Ekbom Disease.
Topics: Animals; Anticonvulsants; Calcium Channels; Carbamates; Gabapentin; gamma-Aminobutyric Acid; Humans; Ligands; Pregabalin; Restless Legs Syndrome | 2018 |
6 trial(s) available for gabapentin and carbamates
| Article | Year |
|---|---|
Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin.
Topics: Adult; Aged; Amines; Area Under Curve; Biological Availability; Capsules; Carbamates; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Half-Life; Headache; Humans; Male; Middle Aged; Molecular Structure; Molecular Weight; Prodrugs; Sleep Wake Disorders; Young Adult | 2008 |
Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Topics: Adult; Amines; Anti-Anxiety Agents; Carbamates; Central Nervous System; Cyclohexanecarboxylic Acids; Disorders of Excessive Somnolence; Dizziness; Double-Blind Method; Drug Administration Schedule; Endpoint Determination; Female; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Placebos; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2009 |
The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.
Topics: Adult; Amines; Anticonvulsants; Area Under Curve; Biological Availability; Carbamates; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dietary Fats; Female; Food-Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Prodrugs; Young Adult | 2010 |
Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
Topics: Adult; Aged; Amines; Analgesics; Carbamates; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Placebos; Treatment Outcome; Young Adult | 2011 |
Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amines; Carbamates; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Models, Biological; Prodrugs; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders; Young Adult | 2013 |
Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
Topics: Adult; Amines; Analgesics, Opioid; Carbamates; Cross-Over Studies; Cyclohexanecarboxylic Acids; Dizziness; Double-Blind Method; Dyssomnias; Electrocardiography; Gabapentin; gamma-Aminobutyric Acid; Healthy Volunteers; Humans; Male; Middle Aged; Morphine; Nausea; Prodrugs; Young Adult | 2015 |
9 other study(ies) available for gabapentin and carbamates
| Article | Year |
|---|---|
Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain.
Topics: Acetates; Amines; Animals; Benzofurans; Carbamates; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Neurokinin-1 Receptor Antagonists; Pain; Pain Measurement; Peripheral Nervous System Diseases; Piperidines; Rats; Rats, Sprague-Dawley | 2002 |
Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Cell Death; Cells, Cultured; Chlordiazepoxide; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Gabapentin; gamma-Aminobutyric Acid; Glucose; Hippocampus; Hypoxia; Ischemia; Lamotrigine; Levetiracetam; Midazolam; Neurons; Neuroprotective Agents; Nipecotic Acids; Oxcarbazepine; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Rats; Rats, Wistar; Tiagabine; Triazines; Valproic Acid | 2003 |
The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Topics: Acute Disease; Amines; Analgesics, Opioid; Animals; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Indoles; Ion Channel Gating; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Peripheral Nervous System Diseases; Phenylenediamines; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Wistar; Spinal Nerves; Touch; Tramadol | 2004 |
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.
Topics: Amines; Animals; Biological Transport; Caco-2 Cells; Carbamates; CHO Cells; Cricetinae; Cyclohexanecarboxylic Acids; Cytochrome P-450 Enzyme System; Dogs; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Intestinal Mucosa; Large Neutral Amino Acid-Transporter 1; Membranes, Artificial; Monocarboxylic Acid Transporters; Prodrugs; Protein Binding; Rats; Symporters | 2004 |
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys.
Topics: Administration, Oral; Amines; Animals; Biological Availability; Carbamates; Colon; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Haplorhini; Injections, Intravenous; Intestinal Absorption; Prodrugs; Rats; Rats, Sprague-Dawley; Species Specificity; Tissue Distribution | 2004 |
Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus.
Topics: Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Chlormethiazole; Clozapine; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Epilepsy; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Guinea Pigs; Hippocampus; In Vitro Techniques; Levetiracetam; Male; Phenylcarbamates; Phenylenediamines; Piracetam; Propylene Glycols; Soman; Topiramate | 2005 |
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
Topics: Amidohydrolases; Amines; Analgesics; Animals; Benzamides; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gabapentin; gamma-Aminobutyric Acid; HIV Envelope Protein gp120; HIV Infections; Hyperalgesia; Male; Nociception; Piperidines; Pyridines; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Sciatic Neuropathy | 2015 |
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
Topics: Age of Onset; Animals; Anticonvulsants; Carbamates; Cells, Cultured; Child; CHO Cells; Cricetinae; Cricetulus; Electroencephalography; Epilepsy; Female; Gabapentin; Humans; KCNQ2 Potassium Channel; Mutation; Phenylenediamines; Precision Medicine; Rats; Treatment Outcome | 2020 |
Interindividual Variability in the Bioavailability of Gabapentin Enacarbil Extended Release in Healthy Adults: An Analysis of Data From 6 Phase I Studies.
Topics: Administration, Oral; Adult; Area Under Curve; Biological Availability; Carbamates; Cross-Over Studies; Gabapentin; gamma-Aminobutyric Acid; Humans | 2022 |